Patent Application
20190224709
This invention relates to an aperture plate for generating an aerosol and to an aerosol generator incorporating the aperture plate. The aerosol generator is particularly suitable for delivery of an aerosol of ophthalmic fluid to the eye.
Aerosol delivery of ophthalmic fluid to the eye is described in U.S. Pat. Nos. 8,012,136 and 8,684,980.
There are a number of problems with known systems of this type. It is difficult to deliver a sufficient amount of the aerosol with effective droplet size sufficiently quickly before involuntary blink reflex and/or lacrimation reflex occurs.
Aerosol generators comprising a vibratable member and a plate body operably coupled to the vibratable member are known. The plate body has a top surface, a bottom surface, and a plurality of apertures extending from the top surface to the bottom surface. The apertures may be tapered such that when a liquid is supplied to one surface and the aperture plate is vibrated using the vibratable member, liquid droplets are ejected from the opposite surface. Details of such known systems are described for example in U.S. Pat. No. 6,235,177, US20070023547A, and U.S. Pat. No. 7,066,398, the entire contents of which are herein incorporated by reference.
According to the invention there is provided an aperture plate comprising:
In one embodiment the aperture plate is substantially domed shaped in geometry
In one case the apertures are tapered to narrow from the inlet opening at the inlet surface to an outlet opening adjacent to the outlet surface. There may be a flared portion adjacent to the exit opening.
The invention also provides an aerosol generator comprising an aperture plate of the invention.
In one embodiment the aerosol generator comprises:
The aerosol generator may comprise a reservoir for liquid to be aerosolised.
In one case the reservoir is defined by a portion of the housing.
In one embodiment the aerosol generator comprises an aperture plate drive circuit having a controller, wherein the controller is configured to pulse the aperture plate in an on-off manner.
In one case the duration of the on-off cycle is less than 20 microseconds.
In one embodiment the support member comprises a central opening and the aperture plate is mounted to the underside of the support member.
The invention also provides an ophthalmic fluid delivery device comprising an aerosol generator of the invention.
The aperture plate may be of any suitable thickness. In one case the aperture plate has a thickness of from 59 to 63 microns.
The invention also provides an aerosol generator comprising an aperture plate of the invention and means for vibrating the aperture plate. The means for vibrating the aperture plate is preferably configured to vibrate the plate at a frequency of from 125 to 155 kHz. The plate may be vibrated at from 128 to 148 kHz.
In one case the aperture plate comprises a plate body having a top surface, a bottom surface, and a plurality of apertures that taper in a direction from the top surface to the bottom surface. Liquid is supplied to the top (rear) surface of the aperture plate, and the aperture plate is vibrated to eject liquid droplets from the bottom (front) surface. Further, the apertures have an exit angle that is in the range from about 30° to about 60° , more preferably about 41° to about 49° , and more preferably at about 45° . The apertures may have a diameter that is in the range from about 1 micron to about 10 microns at the narrowest portion of the taper. Such an aperture plate is advantageous in that it may produce liquid droplets having a size that are in the range from about 2 to 10 microns.
In some cases, in order to produce larger droplets, the outlet openings are at least 10 μm in diameter. Such droplets avoid deflection by the eye.
In some cases the outlet openings are from 10 μm to 20 μm, or from 15 μm to 20 μm in diameter.
In one embodiment the outlet openings are about 20 μm in diameter.
Techniques for vibrating such aperture plates are described generally in U.S. Pat. Nos. 5,164,740; 5,586,550; and 5,758,637, which are incorporated herein by reference. The aperture plates are constructed to permit the production of relatively small liquid droplets at a relatively fast rate.
To enhance the rate of droplet production while maintaining the droplets within a specified size range, the apertures may be constructed to have a certain shape. More specifically, the apertures are preferably tapered such that the aperture is narrower in cross section where the droplet exits the aperture. In one case, the angle of the aperture at the exit opening (or the exit angle) is in the range from about 30° to about 60° , more preferably from about 41° to about 49° , and more preferably at about 45° . Such an exit angle provides for an increased flow rate while minimizing droplet size. In this way, the aperture plate may find particular use with inhalation drug delivery applications.
In some cases may have an exit opening having a diameter in the range from about 1 micron to about 10 microns, to produce droplets that are about 2 microns to about 10 microns in size. The taper at the exit angle is preferably within the desired angle range for at least about the first 15 microns of the aperture plate. Beyond this point, the shape of the aperture is less critical. For example, the angle of taper may increase toward the opposite surface of the aperture plate.
The aperture plate is typically constructed from a palladium nickel alloy. Such an alloy is corrosion resistant to many corrosive materials particularly solutions for treating respiratory diseases by inhalation therapy, such as an albuterol sulfate and ipratropium solution, which is used in many medical applications. Further, the palladium nickel alloy has a low modulus of elasticity and therefore a lower stress for a given oscillation amplitude.
The aperture plates of the invention may be constructed using an electro-deposition process where a metal is deposited from a solution onto a conductive mandrel by an electrolytic process. In one example, the aperture plates are formed using an electroforming process where the metal is electroplated onto an accurately made mandrel that has the inverse contour, dimensions, and surface finish desired on the finished aperture plate. When the desired thickness of deposited metal has been attained, the aperture plate is separated from the mandrel. Electroforming techniques are described generally in E. Paul DeGarmo, “Materials and Processes in Manufacturing” McMillan Publishing Co., Inc., New York, 5.sup.th Edition, 1979, the complete disclosure of which is herein incorporated by reference.
The invention will be more clearly understood from the following description thereof, given by way of example only, in which:
Referring initially to
There is in contrast to prior art aperture plates as illustrated in
We have found that this difference is highly significant. In the case of the prior art aperture plate a diverging aerosol plume is generated as illustrated in
The aperture plate of the invention may be incorporated in any suitable aerosol generator system such as that described in our WO2012/04622A (Aerogen Solo II). The arrangement illustrated in the drawings is given by way of example only.
The aperture plate 1 is mounted to an annular support member or washer 20 which has a central opening. A vibration generating element, in this case an annular shaped piezo 21, is used to vibrate the aperture plate 1. A first electrical power conducting pin 25 engages with a first surface of the piezo 21 and a second conducting pin 26 conducts electrical power to a second surface of the piezo 21.
In the case of the aperture plate of the invention the aperture plate 1 is mounted to the underside of the support washer 20. This assists in creating a reservoir area above the convex (inlet) side of the aperture plate which enhances the efficiency of aerosolisation.
An aerosol generator of the type described in our WO2012/046220A (Aerogen Solo II) was used in this experiment. Two different types of aperture plates were used:
Type A aperture plates with 10 μm outlet openings were evaluated and found to have % dose recovery of 60-75% at a distance of 3 cm and through a 6 mm aperture.
Two Type B 10 μm inversely domed aperture plates were also evaluated through the same setup. The inverse domed Type B aperture plates showed a large increase in dose recovery. The 10 μm INV2-S1 and 10 μm INV2-S2 had recovered doses of 88-99.8% and 90-99.6% respectively.
Type A aperture plates with 15 μm outlet openings were also evaluated and were found to have % dose recovery of 65-83% at a distance of 3 cm and through a 6 mm aperture.
Type B 15 μm inversely domed aperture plates were also evaluated through the same setup. The inversely domed aperture plates showed a large increase in dose recovery. The 15 μm INV2-S2 had recovered doses of 92-98.4%.
Type A aperture plates with 20 μm outlet openings were evaluated and found to have % dose recovery of 65-73% at a distance of 3 cm and through a 6 mm aperture. Two Type B 20 μm inversely domed aperture plates were also evaluated through the same setup. The inverse domed Type B aperture plates showed a large increase in dose recovery. The 20 μm INV2-S1 and 20 μm INV2-S2 had recovered doses of 92-99.1% and 92-99% respectively.
From this experiment it is clear that the doming profile has a large influence on dose delivery. It was observed that aperture plates Type A with the regular dome profile, the average dose recovery was ˜60-75% while the aperture plates Type B with inverse dome was in excess of 90% dose recovery.
The regular dome profile Type A generates a diverging aerosol plume. This diverging aerosol plume is generated by the convex shape dome of the aperture plates. The aerosol was seen to diverge the further it travelled away from the aperture plates.
In complete contrast, the aperture plates Type B have an inverse dome concave shape and the aerosol converged to generate a jet type stream of liquid. This jet type steam of liquid was not seen to diverge again for distances <0.5 meters. The narrow jet type steam of liquid appeared to have a span of less than 6 mm in diameters and this was confirmed by the high dose recovery.
Another important characteristic of the aperture plates was the flow rate. A minimum flowrate of 360 mL/hr was required to achieve the 10 μl in less than 0.1 s.
The 15 μm conventional Type A aperture plates had a flowrate of ˜700 mL/hour, and the Type B aperture plates 15 μm INV2-had a flowrate ˜730 mL/hour.
The 20 μm conventional Type A aperture plates had a flowrate of ˜1340 mL/hour, and the Type B aperture plates 20 μm INV2-S1 and 20 μm INV2-S2 had flowrates ˜1550 mL/hour and 1500 mL/hour respectively.
The inversely domed aperture plates Type B 10, 15 & 20 μm were evaluated at a height of 3 and 4 cm from a target aperture and the aperture size was reduced from 8 to 6 mm. The results show that the height and the aperture hole size did not affect the dose delivery. The dose delivery was recovered across all parameters and ranged from 87.5±2.5%, 81±3% & 81±3% respectively.
In all cases of Type B aperture plates, the required dose delivery was achieved. All the aperture plates were nearly identical in dose delivery however the aperture plates are distinguished based on their flowrates. The flowrates increased proportionally to hole size. The 10, 15 & 20 μm Type B aperture plates had flowrates of 388, 700 and 1552 mL/hr respectively. The initial requirement 15 for dose duration was ≤1 sec. preferably ≤0.5 sec, however this was reduced to 0.1 seconds to deliver the 10 μL dose (360 mL/hr) in an attempt to overcome the blink response. Again all the type B aperture plates met the requirement of 0.1 second. In this case of the 20 μm aperture plates the visual appearance of the aerosol jet was a more defined jet when compared to the 10 and 15 μm devices.
The flowrate of the 20 μm device was seen to be ˜1550 mL/hr, but when this was tested on a person's skin it was found to exert a strong force at the point of impact. In attempts to reduce the force of the jet, several reductions were made to the controller power output however it was seen, as power level decreased below 7 volts, the precision of the jet was affected. As a result of this finding the power output was set at 7 volts. The effect of reducing the power output resulted in a slower flow rate however it was still >>360 mL/hr. A novel approach of a pulsed algorithm was created to reduce the flowrate of the 20 μm device to ˜360 mL/hr. The algorithm was an on-off-on-off-etc. where the duration of the on/off cycle was <20 microseconds. This resulted in the reduction of the flowrate to the required 360 mL/hr. To the naked eye it still appeared as a one continuous jet, however utilising high speed camera analysis it was possible to see that the jet stream was made up of individual droplets caused by the on/off cycle as illustrated in
The aerosol generators of the invention may be used in a wide range of applications including delivery to the eye and precision delivery devices more generally.
Advantages of the invention include:
The invention overcomes at least some of the following problems with prior art device:
Aerosol droplet characteristics (too light and reflects off eye);
Dose Accuracy and precision (plume spreads too wide);
Speed of delivery (slow device flow rate, extends delivery).
Any suitable fluid may be aerosolised using the aperture plate of the invention. The fluid in one case is water. The fluid may be a solution which may contain an agent such as a diagnostic or therapeutic agent. For ophthalmic applications, the fluid may be any type of fluid that is pharmacologically compatible with the eye. In some cases the agent is selected from one or more of diagnostic agents, antibiotics, corticosteroids, antibiotic/corticosteroid combinations, lubricants, tear substitutes, tear production enhancement agents, decongestants, antihistamines, decongestant/antihistamine combination agents, antibacterial agents, antiviral agents, antimicrobial agents, steroidal anti-inflammatory agents, antibiotic/steroidal anti-inflammatory combination agents, nonsteroidal anti-inflammatory agents, topical anesthetic agents, topical anesthetic/fluorescein combination agents, hypertonic saline solution, mydriatic/cycloplegics, miotics, ocular hypotensive agents (anti-glaucoma agents) including: miotics, alpha-adrenergic agents, carbonic anhydrase inhibitors, beta-blocking agents, prostaglandin analogs, combination agents.
The invention is not limited to the embodiments hereinbefore described, which may be varied in construction and detail.
| Number | Date | Country | Kind |
|---|---|---|---|
| 16177850.1 | Jul 2016 | EP | regional |
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/EP2017/066225 | 6/29/2017 | WO | 00 |
